Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Evofem Biosciences Inc (EVFM)

Evofem Biosciences Inc (EVFM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 122,863
  • Shares Outstanding, K 155,208
  • Annual Sales, $ 450 K
  • Annual Income, $ -142,310 K
  • 60-Month Beta -0.33
  • Price/Sales 270.50
  • Price/Cash Flow N/A
  • Price/Book 15.01
Trade EVFM with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.66
  • Most Recent Earnings N/A on 08/11/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 89.95%
  • Historical Volatility 62.92%
  • IV Percentile 1%
  • IV Rank 15.19%
  • IV High 252.67% on 10/15/20
  • IV Low 60.81% on 08/19/21
  • Put/Call Vol Ratio 0.22
  • Today's Volume 602
  • Volume Avg (30-Day) 1,991
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 66,810
  • Open Int (30-Day) 89,562

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.30
  • Number of Estimates 4
  • High Estimate -0.27
  • Low Estimate -0.33
  • Prior Year -0.33
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7501 +1.63%
on 09/21/21
0.9742 -21.75%
on 08/31/21
-0.0358 (-4.49%)
since 08/27/21
3-Month
0.6543 +16.51%
on 08/17/21
1.2400 -38.52%
on 06/29/21
-0.4477 (-37.00%)
since 06/28/21
52-Week
0.6543 +16.51%
on 08/17/21
5.5300 -86.22%
on 02/17/21
-1.4877 (-66.12%)
since 09/28/20

Most Recent Stories

More News
Evofem Biosciences Announces Publication in Peer-Reviewed Journal Advances in Therapy

/PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that a manuscript on the variability of contraceptive clinical trial design and its impact on efficacy outcomes has been published...

EVFM : 0.7550 (-4.43%)
Seven Abstracts to be Presented on Evofem Biosciences' Vaginal pH Modulator

/PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that seven data sets from clinical trials of Phexxi® (lactic acid, citric acid and potassium bitartrate) and EVO100 will be presented...

EVFM : 0.7550 (-4.43%)
Emmy® Award Winner Annie Murphy Partners with Evofem Biosciences to Talk Sex, Contraception, and Why She Chose Phexxi®

/PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced their partnership with Emmy® Award-winning actress to launch "House Rules," a national campaign to generate awareness of Evofem's...

EVFM : 0.7550 (-4.43%)
Evofem Biosciences to Participate in Investor Conferences

/PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Chief Executive Officer will present and host one-on-one meetings at two upcoming investor conferences as follows: 

EVFM : 0.7550 (-4.43%)
Evofem Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Update

/PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), today reported financial results for the three- and six-month periods ended .

EVFM : 0.7550 (-4.43%)
Evofem Biosciences to Report Second Quarter 2021 Results and Provide Corporate Update on Wednesday, August 11, 2021

/PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the second quarter ended June 30, 2021 on at...

EVFM : 0.7550 (-4.43%)
Early Look at Second Quarter Metrics for Phexxi® Reveals Strong Growth

/PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today provided a preliminary look at Phexxi (lactic acid, citric acid and potassium bitartrate) data for the second quarter of 2021 and revealed...

EVFM : 0.7550 (-4.43%)
10 High Short Interest Stocks To Watch Right Now

Stocks with high short-interest have gained the attention of Reddit retail traders in the stock market this year. Here are 10 that you may want to watch if this is something you're interested in right...

GME : 181.37 (-4.28%)
AMC : 37.43 (-4.76%)
VIAC : 40.32 (-0.30%)
DISCA : 25.66 (-1.84%)
BIDU : 154.45 (-1.59%)
TME : 7.11 (-1.52%)
CS : 9.98 (-1.77%)
NMR : 5.14 (-1.91%)
KOSS : 16.67 (-1.07%)
NOK : 5.45 (-3.20%)
TRVG : 2.56 (-4.12%)
BBBY : 22.91 (-3.62%)
BB : 9.82 (-3.16%)
CTRM : 2.63 (-4.01%)
AAL : 21.45 (-0.09%)
EXPR : 5.29 (+0.95%)
CARV : 16.81 (-4.65%)
LI : 26.16 (-2.79%)
WKHS : 8.07 (-2.65%)
DFH : 18.00 (-1.10%)
SPRT : 11.80 (-38.22%)
FUV : 11.43 (-6.00%)
BEEM : 28.77 (-4.07%)
BLNK : 29.06 (-2.91%)
EVFM : 0.7550 (-4.43%)
YALA : 7.18 (-4.01%)
Thinking about buying stock in Anavex Life Sciences, Globalstar, Rapt Therapeutics, Aytu Biopharma, or Evofem Biosciences?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVXL, GSAT, RAPT, AYTU, and EVFM.

GSAT : 1.6700 (-2.91%)
EVFM : 0.7550 (-4.43%)
RAPT : 34.01 (-1.71%)
AVXL : 18.54 (-3.59%)
AYTU : 2.91 (-6.73%)
Does Evofem Biosciences Deserve a Place in Your Portfolio?

Evofem Biosciences (EVFM) has been taking steps to increase awareness about its FDA-approved product—Phexxi. However, the stock has been losing value over the past year on several concerns. So, let’s...

EVFM : 0.7550 (-4.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention...

See More

Key Turning Points

3rd Resistance Point 0.8491
2nd Resistance Point 0.8329
1st Resistance Point 0.8123
Last Price 0.7550
1st Support Level 0.7755
2nd Support Level 0.7593
3rd Support Level 0.7387

See More

52-Week High 5.5300
Fibonacci 61.8% 3.6675
Fibonacci 50% 3.0922
Fibonacci 38.2% 2.5168
Last Price 0.7550
52-Week Low 0.6543

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar